Columbia Threadneedle Investments

  • 1,001-5,000 employees
  • Financial Services

Columbia Threadneedle Investments

At Columbia Threadneedle Investments, we invest to make a difference in your world, and the wider world. Millions of people rely on us to manage their money and invest for their future; together they entrust us with $637 billion*.

We are globally connected with a team of over 650 investment professionals providing diverse expertise, spanning almost every asset class and market. We are intense about research as we believe that original independent research makes investment decisions smarter. We have a responsible ethos as investment decisions today help define the future we all seek. Every day, we’re looking for opportunities to improve how we invest and what our clients experience; our focus on continuous improvement means that we never stand still.

Whatever world you want, our purpose is to help you achieve it.

For professional investors only

This material is for information only and does not constitute an offer or solicitation of an order to buy or sell any securities or other financial instruments, or to provide investment advice or services.

Information contained on this page should not be seen as investment advice or a recommendation.

Important disclosures: http://www.columbiathreadneedle.com/linkedin

*AUM data as at 31 December 2023

Electric1.jpg
Electric Vehicle transition: poised to move through the gears
  • 8 days ago

With cost parity on the horizon, we expect the adoption of electric vehicles to accelerate. We explore the key drivers and related investment opportunities.

By Columbia Threadneedle Investments In Commodities, Sustainability, Thematic / Megatrends
Read More 
FixedIncome3.jpg
In Credit Weekly Snapshot – June 2025
  • 8 days ago

Our fixed income team provide their weekly snapshot of market events.

By Columbia Threadneedle Investments In Fixed Income
Read More 
article7.png
Market perspectives: What a difference a week makes
  • 9 days ago

It has been another extraordinary week of geopolitical developments with the backdrop considerably more benign than a week ago thanks to a tentative ceasefire between Israel and Iran.

By Columbia Threadneedle Investments
Read More 
AI2.png
Market jitters miss the bigger AI picture
  • 12 days ago

As investors navigate a slower growth, policy-fragmented environment, AI stands out as a long-term theme with the potential to deliver durable growth and broad-based opportunity across the value ch...

By Columbia Threadneedle Investments In Thematic / Megatrends, Sustainability, Equities
Read More 
Yield1.png
Resilient European High Yield market looks beyond tariff uncertainty
  • 13 days ago

We cannot ignore the dominant themes impacting markets across the world, but a resilient and supported European marketplace is well placed to prosper in these challenging times.

By Columbia Threadneedle Investments In Fixed Income, Macro
Read More 
galaxy2.png
LDI differentiator: using a Reorganisation Fund
  • 14 days ago

This mini-series of short articles shines a light on often under-discussed but important factors to think about when structuring your LDI investments. In this paper we will discuss disinvestments.

By Columbia Threadneedle Investments
Read More 
CapitalMarkets2.png
Market perspectives: Will the resilience of financial markets be undone by escalating geopolitical risks?
  • 16 days ago

Investors continue to closely follow events in the Middle East – most recently the US’s strikes on three Iranian nuclear sites.

By Columbia Threadneedle Investments In Industry, Macro
Read More 
CapitalMarkets1.png
Asset Allocation update - June 2025
  • 20 days ago

Financial markets continue to display confidence that the trade war remains on a de-escalating path, even as the deadline for ‘trade deals’ to be agreed with the US moves into focus.

By Columbia Threadneedle Investments In Industry, Portfolio Construction, Macro
Read More 
Fixed Income and Bonds.png
A bitter pill: what tariffs could mean for pharmaceutical firms and the wider healthcare industry
  • 21 days ago

Although a drive to onshore manufacturing of pharmaceuticals is admirable, there could be some unintended consequences around price, availability and global relations.

By Columbia Threadneedle Investments In Fixed Income, Macro, Equities
Read More 

Copyright © 2025 Markets Recon. All Rights Reserved.

Markets Recon, operated by Recon Discovery Limited (Registered in England and Wales, Company No. 14778559). Registered Office: 86-90 Paul Street, London EC2A 4NE.